Overview
Updated 14 Jul 2026
Charles Sawyers, MD, is Chair, Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center. The public record shows 639 publications with 104,223 citations (h-index 131), centered on Leukemia (AML/ALL/CML/CLL), Prostate Cancer. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 8 companies, 9 NIH-funded awards (2007–2026).
- Most recent indexed publication: 2026 · Nature
- Top research focus: Leukemia (AML/ALL/CML/CLL)
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 40 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Public positionssourced statements on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- Appointed by President Obama to the National Cancer Advisory Board (NCAB)
2012; later chaired NCAB Subcommittee on Planning and Budget
2012verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia
Sponsor: Jonsson Comprehensive Cancer Center
InvestigatorPhase 1CompletedNCT00345826 - 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate
Sponsor: Jonsson Comprehensive Cancer Center
InvestigatorPhase 1CompletedNCT00100997 - Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse
Sponsor: Jonsson Comprehensive Cancer Center
InvestigatorPhase 2CompletedNCT00071968
Industry payments
Updated 14 Jul 2026
8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20252 payments$1,271,522openpaymentsdata.cms.gov ↗
- Blueprint Medicines CorporationProgram year20254 payments$15,835openpaymentsdata.cms.gov ↗
- BeOne Medicines USA, Inc.Program year20253 payments$11,667openpaymentsdata.cms.gov ↗
NIH funding
Updated 14 Jul 2026
9 NIH research awards on record, funded 2007–2026 per NIH RePORTER. The latest:
- Project 1: Investigation of immune and stromal factors that promote prostate adenocarcinoma progression and castration response
Columbia University Health Sciences
FY2026$507,659P01CA265768 - Leveraging Observational (Real World) Data to Advance Precision Oncology
Sloan-Kettering Inst Can Research
FY2025$2,357,014P01CA275746 - Project 1: Investigation of immune and stromal factors that promote prostate adenocarcinoma progression and castration response
Columbia University Health Sciences
FY2025$487,709P01CA265768
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- Internal medicine residency
University of California, San Francisco
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Editorial & leadership rolesjournal and society appointments
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aacr.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- Past President
American Society for Clinical Investigation (ASCI)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →the-asci.org ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- 2009 Lasker-DeBakey Clinical Medical Research Award (shared with Brian J. Druker and Nicholas Lydon)
for development of imatinib and dasatinib for CML
2009verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →laskerfoundation.org ↗ - Elected member
National Academy of Sciences
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nasonline.org ↗
Secondary affiliationsappointments beyond the home institution
- Professor
Cell and Developmental Biology Program, Weill Cornell Graduate School of Medical Sciences
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →gradschool.weill.cornell.edu ↗ - Faculty listing
Weill Cornell Medicine directory
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.weill.cornell.edu ↗ - Board of Scientific Counselors (Chairman)
Broad Institute of MIT and Harvard
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →broadinstitute.org ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- Featured researcher
PBS/Ken Burns documentary "Cancer: The Emperor of All Maladies"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancerhistoryproject.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- LinkedIn
linkedin.com/in/charles-sawyers-b8a8b517
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by otherswhere others cite or feature them
- LinkedIn
linkedin.com/posts/memorial-sloan-kettering-cancer-center_twenty-years-ago-msks-dr-charles-sawyers-activity-6872901080292892672-QoDi
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - Other
mskcc.org/podcasts/cancer-straight-talk/future-of-cancer-drugs-conversation-with-dr-charles-sawyers
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mskcc.org ↗ - X / Twitter
x.com/MSKCancerCenter/status/2041199385829163121
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
- 1,431
- publications
- 164
- h-index
- 8
- trials
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
- 1,588
- publications
- 150
- h-index
- 18
- trials
Charles Rudin, MD
Memorial Sloan Kettering Cancer Center
- 1,717
- publications
- 135
- h-index
- 15
- trials
Sergio Giralt, MD
Memorial Sloan Kettering Cancer Center
- 1,809
- publications
- 122
- h-index
- 17
- trials